tacrolimus &#160; Turanci (Q411648)

https://www.whocc.no/atc_ddd_index/?code=L04AD02

5 milligram

route of administration ^Turanci

parenteral route of administration ^Turanci

1 reference

https://www.whocc.no/atc_ddd_index/?code=L04AD02

World Health Organisation international non-proprietary name ^Turanci

tacrolimus (Turanci)

2 references

stated in ^Turanci

ChEBI ^Turanci

ChEBI ID ^Turanci

tacrolimus (anhydrous) (Turanci)

retrieved ^Turanci

19 Oktoba 2016

stated in ^Turanci

retrieved ^Turanci

2 Satumba 2019

https://mednet-communities.net/inn/db/ViewINN.aspx?i=6878

tacrolimusum (Dan Kabilar Latin)

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Satumba 2019

https://mednet-communities.net/inn/db/ViewINN.aspx?i=6878

tacrolimus (Faransanci)

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Satumba 2019

https://mednet-communities.net/inn/db/ViewINN.aspx?i=6878

tacrólimus (Sifaniyanci)

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Satumba 2019

https://mednet-communities.net/inn/db/ViewINN.aspx?i=6878

такролимус (Rashanci)

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Satumba 2019

https://mednet-communities.net/inn/db/ViewINN.aspx?i=6878

تاكروليموس (Larabci)

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Satumba 2019

https://mednet-communities.net/inn/db/ViewINN.aspx?i=6878

他克莫司 (Harshen Sinanci)

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Satumba 2019

https://mednet-communities.net/inn/db/ViewINN.aspx?i=6878

found in taxon ^Turanci

Streptomyces hygroscopicus ^Turanci

1 reference

stated in ^Turanci

Enhancement of ascomycin production via a combination of atmospheric and room temperature plasma mutagenesis in Streptomyces hygroscopicus and medium optimization ^Turanci

Streptomyces tacrolimicus ^Turanci

1 reference

stated in ^Turanci

Characterisation of a γ-butyrolactone receptor of Streptomyces tacrolimicus: effect on sporulation and tacrolimus biosynthesis ^Turanci

Streptomyces clavuligerus ^Turanci

2 references

stated in ^Turanci

Liquid chromatography-mass spectrometry characterization of FK506 biosynthetic intermediates in Streptomyces clavuligerus KCTC 10561BP. ^Turanci

stated in ^Turanci

Enhanced FK506 production in Streptomyces clavuligerus CKD1119 by engineering the supply of methylmalonyl-CoA precursor ^Turanci

Penicillium ^Turanci

1 reference

stated in ^Turanci

Amino Acid Conjugated Anthraquinones from the Marine-Derived Fungus Penicillium sp. SCSIO sof101. ^Turanci

medical condition treated ^Turanci

atopic dermatitis ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000148372

harshen aiki ko suna

Turanci

retrieved ^Turanci

13 Disamba 2016

graft-versus-host disease ^Turanci

2 references

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000148372

harshen aiki ko suna

Turanci

retrieved ^Turanci

13 Disamba 2016

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

lupus nephritis ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

interstitial lung disease ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

Conjunctivitis

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

acute graft versus host disease ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

lichen planus ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

autoimmune hepatitis ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

Ulcerative colitis

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

Ciwon Nephrotic

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

polymyositis ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

myasthenia gravis ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

vitiligo ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

significant drug interaction ^Turanci

valganciclovir ^Turanci

nephrotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ganciclovir ^Turanci

nephrotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

cyclosporine ^Turanci

nephrotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

nabumetone ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

naproxen ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

celecoxib ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

Diclofenac ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

piroxicam ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

meloxicam ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-fenoprofen ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(+-)-flurbiprofen ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ibuprofen ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

indomethacin ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-ketoprofen ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-etodolac ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sulindac ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

parecoxib ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

cyclosporine ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

aceclofenac ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

tenoxicam ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

nabumetone ^Turanci

nephrotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

naproxen ^Turanci

nephrotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

celecoxib ^Turanci

nephrotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

Diclofenac ^Turanci

nephrotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

piroxicam ^Turanci

nephrotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

meloxicam ^Turanci

nephrotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-fenoprofen ^Turanci

nephrotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(+-)-flurbiprofen ^Turanci

nephrotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ibuprofen ^Turanci

nephrotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

indomethacin ^Turanci

nephrotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-ketoprofen ^Turanci

nephrotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-etodolac ^Turanci

nephrotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sulindac ^Turanci

nephrotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

foscarnet ^Turanci

nephrotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pentamidine ^Turanci

nephrotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

parecoxib ^Turanci

nephrotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

aceclofenac ^Turanci

nephrotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

tenoxicam ^Turanci

nephrotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

foscarnet ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pentamidine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

dronedarone ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

amiodarone ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

nabumetone ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

naproxen ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

celecoxib ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

Diclofenac ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

piroxicam ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

meloxicam ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-fenoprofen ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(+-)-flurbiprofen ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ibuprofen ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

indomethacin ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-ketoprofen ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-etodolac ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sulindac ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

parecoxib ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

aceclofenac ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

tenoxicam ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ranolazine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

voriconazole ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fosphenytoin ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

itraconazole ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

atazanavir ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

erythromycin ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ritonavir ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

clarithromycin ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

crizotinib ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

saquinavir ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fluconazole ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

Ketoconazole ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

molecular function ^Turanci

FK506 binding ^Turanci

0 references

ta jiki ma'amala da

FKBP prolyl isomerase 1A ^Turanci

subject has role ^Turanci

enzyme inhibitor ^Turanci

1 reference

stated in ^Turanci

IUPHAR/BPS Guide to PHARMACOLOGY ^Turanci

Guide to Pharmacology Ligand ID ^Turanci

6784

harshen aiki ko suna

Turanci

retrieved ^Turanci

17 Agusta 2016

route of administration ^Turanci

oral administration ^Turanci

0 references

intravenous infusion and defusion ^Turanci

0 references

legal status (medicine) ^Turanci

boxed warning ^Turanci

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

laƙabi

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (Turanci)

pregnancy category ^Turanci

Australian pregnancy category C ^Turanci

1 reference

an ɗauko daga

English Wikipedia ^Turanci

US pregnancy category C ^Turanci

1 reference

an ɗauko daga

English Wikipedia ^Turanci

manufacturer ^Turanci

Pfizer ^Turanci

1 reference

https://www.pfizer.com/products/product-list

subject has role ^Turanci

enzyme inhibitor ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000148372

retrieved ^Turanci

5 Maris 2018

immunosuppressive drug ^Turanci

0 references

Commons category ^Turanci

Tacrolimus

0 references

Identifiers

National Library of Israel J9U ID ^Turanci

987007549156305171

1 reference

stated in ^Turanci

National Library of Israel ^Turanci

Library of Congress authority ID ^Turanci

sh94005977

1 reference

https://github.com/JohnMarkOckerbloom/ftl/blob/master/data/wikimap

retrieved ^Turanci

3 Afirilu 2019

InChI ^Turanci

InChI=1S/C44H69NO12/c1-10-13-31-19-25(2)18-26(3)20-37(54-8)40-38(55-9)22-28(5)44(52,57-40)41(49)42(50)45-17-12-11-14-32(45)43(51)56-39(29(6)34(47)24-35(31)48)27(4)21-30-15-16-33(46)36(23-30)53-7/h10,19,21,26,28-34,36-40,46-47,52H,1,11-18,20,22-24H2,2-9H3/b25-19+,27-21+/t26-,28+,29+,30-,31+,32-,33+,34-,36+,37-,38-,39+,40+,44+/m0/s1

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

tacrolimus (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

InChIKey ^Turanci

QJJXYPPXXYFBGM-LFZNUXCKSA-N

2 references

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

tacrolimus (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

stated in ^Turanci

ChEBI release 2020-09-01 ^Turanci

CAS Registry Number ^Turanci

104987-11-3

2 references

stated in ^Turanci

Global Substance Registration System ^Turanci

UNII ^Turanci

tacrolimus anhydrous (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

InChIKey ^Turanci

QJJXYPPXXYFBGM-LFZNUXCKSA-N

stated in ^Turanci

CAS Common Chemistry ^Turanci

retrieved ^Turanci

9 Afirilu 2021

https://commonchemistry.cas.org/detail?cas_rn=104987-11-3

ChemSpider ID ^Turanci

393220

1 reference

stated in ^Turanci

ChemSpider ^Turanci

ChemSpider ID ^Turanci

Tacrolimus (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

PubChem CID ^Turanci

445643

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

tacrolimus (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

Reaxys registry number ^Turanci

3647477

1 reference

stated in ^Turanci

ChEBI ^Turanci

ChEBI ID ^Turanci

tacrolimus (anhydrous) (Turanci)

retrieved ^Turanci

19 Oktoba 2016

8821611

1 reference

stated in ^Turanci

ChEBI ^Turanci

ChEBI ID ^Turanci

tacrolimus (anhydrous) (Turanci)

retrieved ^Turanci

19 Oktoba 2016

ChEBI ID ^Turanci

61049

mapping relation type ^Turanci

exact match ^Turanci

1 reference

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

TACROLIMUS (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

ChEMBL ID ^Turanci

CHEMBL269732

1 reference

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

TACROLIMUS (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

UniChem compound ID ^Turanci

184250

1 reference

stated in ^Turanci

UniChem ^Turanci

HSDB ID ^Turanci

8195

1 reference

stated in ^Turanci

Hazardous Substances Data Bank ^Turanci

HSDB ID ^Turanci

8195

ranar wallafa

28 Oktoba 2019

laƙabi

Tacrolimus (Turanci)

retrieved ^Turanci

10 Mayu 2021

DSSTox substance ID ^Turanci

DTXSID5046354

1 reference

stated in ^Turanci

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard ^Turanci

DSSTOX compound identifier ^Turanci

DTXCID3026354

0 references

EC number ^Turanci

627-021-3

1 reference

stated in ^Turanci

ECHA Substance Infocard database ^Turanci

ECHA Substance Infocard ID ^Turanci

100.155.367

retrieved ^Turanci

27 Disamba 2018

laƙabi

(3S,4R,5R,8R,9Z,12R,14S,15R,16S,18R,19R,26aS)-8-allyl-5,19-dihydroxy-3-{(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylvinyl}-14,16-dimethoxy-4,10,12,18-tetramethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone (Turanci)

quotation ^Turanci

CAS no.: 104987-11-3 (Turanci)

ECHA Substance Infocard ID ^Turanci

100.155.367

1 reference